Antibiotic azithromycin can cause cardiovascular death: Study - in.com

New Delhi/Mumbai: A US study has found that the commonly used antibiotic, azithromycin, poses a big threat to the heart. The study published in the New England Journal of Medicine says that azithromycin can cause cardiovascular death. According ...

Popular Antibiotic May Raise Risk of Sudden Death - New York Times

A new study finds that a widely used antibiotic, azithromycin, may increase the likelihood of sudden death in adults, especially those who have heart disease or are at high risk for it. Two related antibiotics, erythromycin and clarithromycin ...

Zithromax (azithromycin): FDA Statement on risk of cardiovascular death - Center for Food Safety and Applied Nutrition

ISSUE: FDA notified healthcare professionals that it is aware of the study published in the New England Journal of Medicine May 17, 2012 reporting a small increase in cardiovascular deaths, and in the risk of death from any cause, in persons treated with a ...

Z-Pak Heart Attack? - WebMD

May 16, 2012 -- Sudden heart death may be a new risk from the commonly prescribed antibiotic azithromycin-- better known as Zithromax or the Z-Pak. The finding comes from a study of Medicaid patients who received some 348,000 Z-Pak prescriptions ...

Z-pak’ antibiotic raises cardio death risk, study finds - Washington Post

The antibiotic azithromycin, better known as the five-day “Z-pak,” typically does a great, and fast, job of combating such bacterial illnesses as sinus infections and bronchitis. But research published Wednesday evening in the May 17 issue ...

Study finds common antibiotic azithromycin carries heart risk - medicalxpress.com

Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a "Z-pack." The study found a 2.5-fold higher risk of death from cardiovascular death in the first five days of taking ...

FDA to Review CV Risk With Azithromycin After NEJM Study - Medscape News

May 17, 2012 — The US Food and Drug Administration (FDA) will review a new study showing that patients taking azithromycin (Zithromax, Pfizer) face a small increased risk for sudden cardiac death compared with patients taking amoxicillin ...

Study Links Antibiotic to Slight Rise in Heart Patients' Death Risk - YAHOO!

WEDNESDAY, May 16 (HealthDay News) -- The widely prescribed antibiotic azithromycin may slightly raise the risk of death in patients with heart disease, a new study suggests. Several antibiotics have been tied to an increased risk of sudden death among ...

FDA Statement regarding azithromycin (Zithromax) and the risk of cardiovascular death - Center for Food Safety and Applied Nutrition

[05-17-2012] The U.S. Food and Drug Administration (FDA) is aware of the study published in the New England Journal of Medicine, on May 17, 2012, that compared the risks of cardiovascular death in patients treated with azithromycin (Zithromax), amoxicillin ...